Khairul Niza Abdul Razak

Khairul Niza Abdul Razak

Auto-generated profile, based on publicly available information

Khairul Niza Abdul Razak

School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang 11800, Malaysia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2015 in Nutrients
Verified
Journal Article
Open access
PDF file
NYNor Adlin Yusoff
Nor Adlin Yusoff
MAMariam Ahmad
Mariam Ahmad
BHBassel Al Hindi
Bassel Al Hindi
TWTri Widyawati
Tri Widyawati
MYMun Fei Yam
Mun Fei Yam
MAMohd Zaini Asmawi
Mohd Zaini Asmawi
Nypa fruticans Wurmb. vinegar, commonly known as nipa palm vinegar (NPV) has been used as a folklore medicine among the Malay community to treat diabetes. Early work has shown that aqueous extract (AE) of NPV exerts a potent antihyperglycemic effect. Thus, this study is conducted to evaluate the effect of AE on postprandial hyperglycemia in an attempt to understand its mechanism of antidiabetic action. AE were tested via in vitro intestinal glucose absorption, in vivo carbohydrate tolerance tests and spectrophotometric enzyme inhibition assays. One mg/mL of AE showed a comparable outcome to the use of phloridzin (1 mM) in vitro as it delayed glucose absorption through isolated rat jejunum more effectively than acarbose (1 mg/mL). Further in vivo confirmatory tests showed AE (500 mg/kg) to cause a significant suppression in postprandial hyperglycemia 30 min following respective glucose (2 g/kg), sucrose (4 g/kg) and starch (3 g/kg) loadings in normal rats, compared to the control group. Conversely, in spectrophotometric enzymatic assays, AE showed rather a weak inhibitory activity against both α-glucosidase and α-amylase when compared with acarbose. The findings suggested that NPV exerts its anti-diabetic effect by delaying carbohydrate absorption from the small intestine through selective inhibition of intestinal glucose transporters, therefore suppressing postprandial hyperglycemia.

23 August 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
NYNor Adlin Yusoff
Nor Adlin Yusoff
VLVuanghao Lim
Vuanghao Lim
BHBassel Al Hindi
Bassel Al Hindi
KRKhairul Niza Abdul Razak
Khairul Niza Abdul Razak
TWTri Widyawati
Tri Widyawati
MAMohd Zaini Asmawi
Mohd Zaini Asmawi
Background: An aqueous extract (AE) of vinegar made from Nypa fruticans Wurmb. can improve postprandial glucose levels in normoglycaemic rats. The aim of this study was to evaluate its antihyperglycaemic activity further using in vivo and in vitro approaches. Methods: AE was administered to streptozotocin (STZ)-induced diabetic rats twice daily at three doses (1000, 500, and 250 mg/kg b.w.) for 12 days p.o. Several biochemical analyses and a histological study of the pancreas and liver were performed, accompanied by a cell culture assay. Results: As compared to diabetic control (DC), AE at the doses of 500 and 1000 mg/kg b.w. caused significant reduction (p < 0.05) of blood glucose, total cholesterol and triglycerides levels, with positive improvement of serum insulin levels. Interestingly, immunohistochemical staining of the pancreas suggested no β-cell regeneration, despite significant increase in insulin production. AE-treated groups, however, showed overall restoration of the hepatic histoarchitecture of STZ-induced liver damage, suggesting a possible hepatoprotective effect. The pancreatic effect of AE was further studied through RIN-5F cell culture, which revealed a positive stimulatory effect on insulin release at a basal glucose concentration (1.1 mM). Conclusion: Nypa fruticans Wurmb. vinegar’s aqueous extract exerts its antihyperglycaemic activity, at least in part, through insulin stimulatory and hepatoprotective effects.

29 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
MAMaram Alhawarri
Maram Alhawarri
RDRoza Dianita
Roza Dianita
KRKhairul Niza Abd Razak
Khairul Niza Abd Razak
SMSuriani Mohamad
Suriani Mohamad
TNToshihiko Nogawa
Toshihiko Nogawa
HWHabibah A. Wahab
Habibah A. Wahab
Despite being widely used traditionally as a general tonic, especially in South East Asia, scientific research on Cassia timoriensis, remains scarce. In this study, the aim was to evaluate the in vitro activities for acetylcholinesterase (AChE) inhibitory potential, radical scavenging ability, and the anti-inflammatory properties of different extracts of C. timoriensis flowers using Ellman’s assay, a DPPH assay, and an albumin denaturation assay, respectively. With the exception of the acetylcholinesterase activity, to the best of our knowledge, these activities were reported for the first time for C. timoriensis flowers. The phytochemical analysis confirmed the existence of tannins, flavonoids, saponins, terpenoids, and steroids in the C. timoriensis flower extracts. The ethyl acetate extract possessed the highest phenolic and flavonoid contents (527.43 ± 5.83 mg GAE/g DW and 851.83 ± 10.08 mg QE/g DW, respectively) as compared to the other extracts. In addition, the ethyl acetate and methanol extracts exhibited the highest antioxidant (IC50 20.12 ± 0.12 and 34.48 ± 0.07 µg/mL, respectively), anti-inflammatory (92.50 ± 1.38 and 92.22 ± 1.09, respectively), and anti-AChE (IC50 6.91 ± 0.38 and 6.40 ± 0.27 µg/mL, respectively) activities. These results suggest that ethyl acetate and methanol extracts may contain bioactive compounds that can control neurodegenerative disorders, including Alzheimer’s disease, through high antioxidant, anti-inflammatory, and anti-AChE activities.

18 September 2022 in Heliyon
Verified
Journal Article
Open access
RZRaghdaa Hamdan Al Zarzour
Raghdaa Hamdan Al Zarzour
EKEzatul Ezleen Kamarulzaman
Ezatul Ezleen Kamarulzaman
FSFadi G. Saqallah
Fadi G. Saqallah
FZFauziahanim Zakaria
Fauziahanim Zakaria
MAMuhammad Asif
Muhammad Asif
KRKhairul Niza Abdul Razak
Khairul Niza Abdul Razak
Extensive attention has been focused on herbal medicine for the treatment of different endocrine disorders. In fact, compelling scientific evidence indicates that natural compounds might act as endocrine modulators by mimicking, stimulating, or inhibiting the actions of different hormones, such as thyroid, sex, steroidal, and glucose regulating hormones. These potentials might be effectively employed for therapeutic purposes related to the endocrine system as novel complementary choices. Nevertheless, despite the remarkable therapeutic effects, inadequate targeting efficiency and low aqueous solubility of the bioactive components are still essential challenges in their clinical accreditation. On the other hand, nanotechnology has pushed the wheels of combining inorganic nanoparticles with biological structures of medicinal bioactive compounds as one of the utmost exciting fields of research. Nanoparticle conjugations create an inclusive array of applications that provide greater compliance, higher bioavailability, and lower dosage. This can safeguard the global availability of these wealthy natural sources, regardless of their biological occurrence. This review inspects future challenges of medicinal plants in various endocrine disorders for safe and alternative treatments with examples of their nanoparticle formulations.

13 February 2021 in Food Research
Verified
Journal Article
Closed access
FYF. Yasmin
F. Yasmin
KRK.N. Abdul Razak
K.N. Abdul Razak
NSNOZLENA ABDUL SAMAD
NOZLENA ABDUL SAMAD
TWTri Widyawati
Tri Widyawati
NYN.A. Yusoff
N.A. Yusoff
Vinegar is regarded as a fine example of a traditional food that has several medicinal values. It is used as a home-remedy for the management of diabetes and obesity. We investigated how selected vinegar inhibit the digestive enzymes involved in carbohydrate and lipid metabolism. A total of seven types of vinegar were examined as follows: apple cider (ACV), balsamic (BV), brown rice (BRV), distilled white (DWV), malt (MV), nipah palm (NPV), and red wine (RWV) vinegar. In vitro enzyme inhibition tests were performed using α-amylase and lipase from porcine pancreas, and α-glucosidase from Saccharomyces cerevisiae. In the α-amylase assay, NPV (IC50 = 60.97±1.71 mg/mL) exhibited the strongest inhibitory effect, while RWV (IC50 =786.7±0.96 mg/mL) showed the lowest inhibitory effect. RWV (IC50 =92.49±1.51 mg/mL), by contrast, had the highest inhibitory effect against α-glucosidase and was followed by NPV (IC50 = 227.5±1.06 mg/ mL) and BRV (IC50 = 565.1±2.65 mg/mL). All of the samples showed potent inhibitory effects against pancreatic lipase, with MV having the strongest and ACV the lowest effects, respectively. IC50 values ranged from 48.45 mg/mL to 399.8 mg/mL. A concentration-dependent inhibitory effect was recorded for each of the vinegar against all three tested enzymes. None of the vinegar, however, exceeded the effects recorded for the standard drugs. Interestingly, a weak correlation was found between total acidity and enzyme inhibition, which asserted the presence of bioactive compounds in the vinegar. As a conclusion, vinegar can be incorporated into the diet to lower the meal’s glycaemic index and benefit those at risk of diabetes as well as diabetics.

31 July 2025 in Tropical Life Sciences Research
Verified
Journal Article
Open access
PDF file
MSMeyyammai Swaminathan
Meyyammai Swaminathan
MAMariam Ahmad
Mariam Ahmad
KRKhairul Niza Abdul Razak
Khairul Niza Abdul Razak
NYNor Adlin Yusoff
Nor Adlin Yusoff
GAGabriel Akyirem Akowuah
Gabriel Akyirem Akowuah
VMVikneswaran Murugaiyah
Vikneswaran Murugaiyah
Swietenia macrophylla (S. macrophylla), commonly known as “sky fruit”, belongs to the Meliaceae family and is predominantly distributed in the neotropical areas of Central America, Southern Asia and the Pacific region. The plant has a rich tradition of being utilised for its anti-diabetic properties and other health benefits. This study focused on the S. macrophylla seeds ethanolic extract (SMEE) to explore its antihyperglycemic effects in Goto-Kakizaki (GK) Type 2 diabetic rats. Bioactive compounds were extracted using maceration, and a reversed-phase high-performance liquid chromatography (RPHPLC) method was validated to separate two limonoids, swietenine and 3,6-O,O diacetyl swietenolide, from the extracts. The 500 mg/kg SMEE dosage significantly reduced fasting blood glucose levels, making it the selected treatment dose. The SMEE group consistentlyimproved glucose regulation during oral glucose tolerance test (OGTT) on the first (9.88 ± 0.69 mmol/L) and eighth (6.12 ± 0.30 mmol/L) days, showing lower initial fasting blood glucose levels. The RP-HPLC method validation confirmed high linearity, ensuring precise quantification within the 1.56 ?g/mL to 200 ?g/mL range for swietenine and 3,6-O,O diacetyl swietenolide. The content of these compounds in 1 mg of SMEE was determined as 27.5 ?g (2.75%) and 14.53 ?g (1.45%), respectively. This study provides robust evidence supporting the antihyperglycaemic properties of S. macrophylla seeds. Future studies could evaluate the long-term metabolic effects of S. macrophylla extract on glucose metabolism, oxidative stress and liver function.